ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/29/2026
Back to search
Official data from USPTO
QLETLI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
01/30/2026
Trademark type
Word
Nice classes
5
Filing date
11/21/2018
Registration date
04/07/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/07/2020
Last transaction
01/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
CN
Examiner
LAVACHE, LINDA M
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Bio-Thera Solutions, Ltd.
Bio-Thera Solutions, Ltd.
Representatives
Zhi Dong Hamre, Schumann, Mueller & Larson, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of cancertumorautoimmune diseasesdiabetescardiovascular diseasesophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancertumorautoimmune diseasesdiabetescardiovascular diseasesophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancertumorautoimmune diseasesdiabetescardiovascular diseasesophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancertumorautoimmune diseasesdiabetescardiovascular diseasesophthalmic diseases; medicines for use in humans for the prevention and treatment of cancertumorautoimmune diseasesdiabetescardiovascular diseasesophthalmic diseases
Publications
History of USPTO decisions and trademark events.
28 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/07/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/29/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/12/2020
FIMP
FINAL DISPOSITION PROCESSED
08/12/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/21/2020
PUBO
PUBLISHED FOR OPPOSITION
01/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/13/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/13/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/13/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/13/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/13/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/13/2019
ALIE
ASSIGNED TO LIE
12/13/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2019
RFNT
REFUSAL PROCESSED BY IB
08/02/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/16/2019
RFRR
REFUSAL PROCESSED BY MPU
07/16/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/24/2019
CNRT
NON-FINAL ACTION WRITTEN
06/23/2019
MAFR
APPLICATION FILING RECEIPT MAILED
06/22/2019
DOCK
ASSIGNED TO EXAMINER
06/18/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/18/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/13/2019
Continuous trademark protection
Get notified about every new filing that threatens QLETLI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.